EPISODE · Nov 2, 2020 · 29 MIN
COVID-19: The New Normal with Heather Prendergast
from Clinician's Brief: The Podcast · host Brief Media
In this episode, host Beckie Mossor, RVT, speaks with Heather Prendergast, RVT, CVPM, SPHR, about the challenges—and opportunities—stemming from the COVID-19 pandemic that our industry faces. With her background in practice management and human resources, Heather explains how veterinary clinics have adapted by embracing technology and telehealth. She also delves into new roles, ways to utilize team members, and why top-notch customer service is now more important than ever.Brought to you by Claro® (florfenicol, terbinafine, mometasone furoate) Otic Solution, the only one-dose treatment for canine otitis externa.CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. CONTRAINDICATIONS: Do not use in dogs with known tympanic membrane perforation. CLARO® is contraindicated in dogs with known or suspected hypersensitivity to florfenicol, terbinafine hydrochloride, or mometasone furoate.Full Prescribing Information: https://bit.ly/33CeuguContact us:[email protected] to find us:Cliniciansbrief.com/podcastsFacebook.com/clinciansbriefTwitter: @cliniciansbriefInstagram: @clinicians.briefThe Team:Beckie Mossor, RVT - HostAlexis Ussery - Producer & Digital Content CoordinatorRandall Stupka - Podcast Production & Sound EditingMichelle Munkres - Senior Director of Content
What this episode covers
In this episode, host Beckie Mossor, RVT, speaks with Heather Prendergast, RVT, CVPM, SPHR, about the challenges—and opportunities—stemming from the COVID-19 pandemic that our industry faces. With her background in practice management and human resources, Heather explains how veterinary clinics have adapted by embracing technology and telehealth. She also delves into new roles, ways to utilize team members, and why top-notch customer service is now more important than ever. Brought to you by Claro® (florfenicol, terbinafine, mometasone furoate) Otic Solution, the only one-dose treatment for canine otitis externa. CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. CONTRAINDICATIONS: Do not use in dogs with known tympanic membrane perforation. CLARO® is contraindicated in dogs with known or suspected hypersensitivity to florfenicol, terbinafine hydrochloride, or mometasone furoate. Full Prescribing Information: https://bit.ly/33Ceugu Contact us: [email protected] Where to find us: Cliniciansbrief.com/podcasts Facebook.com/clinciansbrief Twitter: @cliniciansbrief Instagram: @clinicians.brief The Team: Beckie Mossor, RVT - Host Alexis Ussery - Producer & Digital Content Coordinator Randall Stupka - Podcast Production & Sound Editing Michelle Munkres - Senior Director of Content
NOW PLAYING
COVID-19: The New Normal with Heather Prendergast
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m